{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Cardiac+Ischemia&page=30", "query": { "condition": "Cardiac Ischemia", "page": 30 }, "page_size": 10 }, "pagination": { "page": 30, "page_size": 10, "total_count": 2293, "total_pages": 230, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Cardiac+Ischemia&page=31&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Cardiac+Ischemia&page=29&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-24T06:02:25.460Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06763549", "title": "COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cardiopulmonary Failure", "Myocardial Infarction (MI)", "Heart Decompensation", "Heart Failure", "HFrEF - Heart Failure with Reduced Ejection Fraction", "HFpEF - Heart Failure with Preserved Ejection Fraction", "Syncopation", "Syncope", "Ischemic Cardiovascular Disease", "STEMI", "STEMI (ST Elevation MI)", "Atrial Fibrillation (AF)", "Atrial Enlargement", "LVF", "Conduction Defect", "Conduction Abnormalities", "Heart Block", "Valvular Diseases", "Cardiac Output, Low", "Stroke Volume", "Stroke Volume Variation", "Hyperkalemia", "Hypercalcemia", "Hypocalcemia", "LV Dysfunction", "QT Prolongation", "Sudden Cardiac Death Due to Cardiac Arrhythmia", "Ventricular Arrhythmia", "Pacing", "Pacing Induced Dyssynchrony", "Silent Ischemia", "Pericarditis", "Sleep Related Breathing Disorder", "RSA", "Apnea, Obstructive", "Cardiac Output Measurement", "Respiratory Impedance", "CRT And/or ICD", "Infarction", "Cardiomyopathies, Primary", "Hypertrophy" ], "interventions": [ { "name": "SUBPROTOCOL A", "type": "DEVICE" }, { "name": "SUBPROTOCOL B", "type": "DEVICE" }, { "name": "SUBPROTOCOL C", "type": "DEVICE" }, { "name": "SUBPROTOCOL D", "type": "DEVICE" }, { "name": "SUBPROTOCOL E", "type": "DEVICE" }, { "name": "SUBPROTOCOL F", "type": "DEVICE" }, { "name": "SUBPROTOCOL G", "type": "DEVICE" }, { "name": "SUBPROTOCOL H", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Peerbridge Health, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 15000, "start_date": "2024-11-16", "completion_date": "2026-04-15", "has_results": false, "last_update_posted_date": "2025-01-08", "last_synced_at": "2026-10-24T06:02:25.460Z", "location_count": 1, "location_summary": "Melbourne, Florida", "locations": [ { "city": "Melbourne", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06763549" }, { "nct_id": "NCT00927693", "title": "Early Identification of Subclinical Atherosclerosis Using Non-Invasive Imaging Research (EISNER)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Atherosclerosis", "Coronary Artery Disease" ], "interventions": [ { "name": "Coronary Artery Calcium (CAC) Scan", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Cedars-Sinai Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "45 Years to 80 Years" }, "enrollment_count": 2137, "start_date": "2001-02", "completion_date": "2010-08", "has_results": false, "last_update_posted_date": "2011-09-29", "last_synced_at": "2026-10-24T06:02:25.460Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00927693" }, { "nct_id": "NCT01594333", "title": "Cardiovascular Inflammation Reduction Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cardiovascular Disease" ], "interventions": [ { "name": "Methotrexate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4786, "start_date": "2013-04", "completion_date": "2019-10-30", "has_results": true, "last_update_posted_date": "2020-07-24", "last_synced_at": "2026-10-24T06:02:25.460Z", "location_count": 404, "location_summary": "Birmingham, Alabama • Fort Payne, Alabama • Guntersville, Alabama + 296 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fort Payne", "state": "Alabama" }, { "city": "Guntersville", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT01594333" }, { "nct_id": "NCT00120289", "title": "Niacin Plus Statin to Prevent Vascular Events", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cardiovascular Diseases", "Heart Diseases", "Cerebrovascular Accident", "Coronary Disease", "Atherosclerosis", "Myocardial Infarction" ], "interventions": [ { "name": "Extended release niacin", "type": "DRUG" }, { "name": "Simvastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Axio Research. LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": null, "sex": "ALL", "summary": "45 Years and older" }, "enrollment_count": 3414, "start_date": "2005-09", "completion_date": "2012-12", "has_results": true, "last_update_posted_date": "2016-04-06", "last_synced_at": "2026-10-24T06:02:25.460Z", "location_count": 68, "location_summary": "Birmingham, Alabama • Hoover, Alabama • Pheonix, Arizona + 52 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Hoover", "state": "Alabama" }, { "city": "Pheonix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00120289" }, { "nct_id": "NCT02227368", "title": "Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Peripheral Artery Disease (PAD)" ], "interventions": [ { "name": "Ticagrelor", "type": "DRUG" }, { "name": "Comparator", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "130 Years", "sex": "ALL", "summary": "50 Years to 130 Years" }, "enrollment_count": 40, "start_date": "2014-10-20", "completion_date": "2016-05-23", "has_results": true, "last_update_posted_date": "2017-07-19", "last_synced_at": "2026-10-24T06:02:25.460Z", "location_count": 10, "location_summary": "Daytona Beach, Florida • Jacksonville, Florida • Ocala, Florida + 7 more", "locations": [ { "city": "Daytona Beach", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Ocala", "state": "Florida" }, { "city": "Sarasota", "state": "Florida" }, { "city": "Munster", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT02227368" }, { "nct_id": "NCT00715455", "title": "Feasibility and Safety Study Comparing REG1 Anticoagulation System With Unfractionated Heparin in Elective PCI", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Coronary Artery Disease" ], "interventions": [ { "name": "REG1", "type": "DRUG" }, { "name": "Unfractionated Heparin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regado Biosciences, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 26, "start_date": "2007-10", "completion_date": "2008-10", "has_results": false, "last_update_posted_date": "2013-05-31", "last_synced_at": "2026-10-24T06:02:25.460Z", "location_count": 5, "location_summary": "Indianapolis, Indiana • Detroit, Michigan • Chapel Hill, North Carolina + 2 more", "locations": [ { "city": "Indianapolis", "state": "Indiana" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Danville", "state": "Pennsylvania" }, { "city": "Rapid City", "state": "South Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00715455" }, { "nct_id": "NCT06600178", "title": "Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Angina Patients With Non-obstructive Coronary Artery Disease", "Coronary Microvascular Disease", "Coronary Microvascular Dysfunction (CMD)" ], "interventions": [ { "name": "Brenzavvy (bexagliflozin), 20 mg Oral Tablet", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Virginia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 150, "start_date": "2025-07-15", "completion_date": "2029-06-29", "has_results": false, "last_update_posted_date": "2026-09-09", "last_synced_at": "2026-10-24T06:02:25.460Z", "location_count": 1, "location_summary": "Charlottesville, Virginia", "locations": [ { "city": "Charlottesville", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06600178" }, { "nct_id": "NCT04304508", "title": "Study to Gather Information About Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following a Recent Non Cardioembolic Ischemic Stroke Which Occurs When a Blood Clot Has Formed Somewhere in the Human Body (But Not in the Heart) Travelled to the Brain.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Non-cardioembolic Ischemic Stroke" ], "interventions": [ { "name": "BAY2433334", "type": "DRUG" }, { "name": "BAY2433334 matching placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": null, "sex": "ALL", "summary": "45 Years and older" }, "enrollment_count": 1808, "start_date": "2020-06-15", "completion_date": "2022-02-18", "has_results": true, "last_update_posted_date": "2023-04-19", "last_synced_at": "2026-10-24T06:02:25.460Z", "location_count": 5, "location_summary": "Tampa, Florida • Golden Valley, Minnesota • Kansas City, Missouri + 2 more", "locations": [ { "city": "Tampa", "state": "Florida" }, { "city": "Golden Valley", "state": "Minnesota" }, { "city": "Kansas City", "state": "Missouri" }, { "city": "Greensboro", "state": "North Carolina" }, { "city": "Erie", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04304508" }, { "nct_id": "NCT05394181", "title": "Notify 2: An Evaluation of the Impact of Notification of Incidental Coronary Artery Calcium on Statin Rates", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Coronary Artery Disease" ], "interventions": [ { "name": "Notification", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 0, "start_date": "2022-08-01", "completion_date": "2023-03-15", "has_results": false, "last_update_posted_date": "2026-02-27", "last_synced_at": "2026-10-24T06:02:25.460Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05394181" }, { "nct_id": "NCT02287909", "title": "Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Coronary Artery Disease" ], "interventions": [ { "name": "Clopidogrel", "type": "DRUG" }, { "name": "Ticagrelor", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 87, "start_date": "2014-12", "completion_date": "2018-03", "has_results": true, "last_update_posted_date": "2020-09-16", "last_synced_at": "2026-10-24T06:02:25.460Z", "location_count": 1, "location_summary": "Jacksonville, Florida", "locations": [ { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02287909" } ] }